Subham Preetam is a professional biotechnologist who collaborates with a creative bio-robotics researcher. His area of expertise lies in early-stage research in biomedical robotics engineering, with a particular interest in quantum engineering for the manufacturing of bio-hybrid robots. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals.

With extensive cross-disciplinary training and experience in translational research, Mr. Preetam is currently focused on various research topics, including micro-robotics, soft bio-hybrid robots, and quantum nanorobot fabrication for removing heavy metals from ocean water. His research aims to improve the life expectancy of sea animals and humans.

Furthermore, he is involved in developing a bio-fluidics nanomedicine system that leverages the latest drug delivery technologies to create personalized solutions for brain cancer patients in South Korea and Sweden. Additionally, he collaborates with researchers from India, Taiwan, Israel, Saudi Arabia, the US, China, Denmark, Singapore, Spain, Portugal, and the United Kingdom on various collaborative projects.

iam graduated from faculty of science, chemistry and biochemistry dep. i have a biomedical analysis diploma. my master degree focused in treatment diabetes with the combination therapy using natural products and a pharmaceutical. i hope to find a PHD position in biochemistry. mainly my interest in biochemistry. title of thesis( treatment of HFD induced diabetes with combination of metformin and natural products)

Dr. Isabel Varela-Nieto graduated and earned her doctorate in Chemistry, Biochemistry Section, at the University Complutense of Madrid (Spain). She has been a visiting guest scientist at the Medical Schools of Uppsala (FEBS Fellow, Sweden) and San Diego (MEC Sabbatical, USA). She is Professor of Research at the CSIC and group leader at the CIBER of rare diseases (CIBERER, ISCIII) in Madrid. From the early 1990s she has been studying hearing neurobiology and IGF-1 actions. She was the first Chair of the SEBBM Science for Society working group with which she actively collaborates, and member of the FEBS Network working group. She is currently the president of the SEBBM, a member of the FEBS Science and Society Committee and of the ISC Finances Committee.